Delivery Order SPE2DB20D2104-SPE2DB25FMXTE
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $6,671.60 to AmerisourceBergen Drug Corp for 30 tablets of Tivicay 50 mg on July 23, 2025, with completion expected by July 24, 2025. This firm fixed price delivery order, with no set-aside designation, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Tivicay is an antiretroviral medication used in HIV treatment, reflecting the Defense Logistics Agency's ongoing pharmaceutical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,334.31 for 30-tablet units of Tivicay 50 mg tablets, a pharmaceutical product used in HIV treatment. The contract was awarded on August 4, 2025, with an ultimate completion date of August 5, 2025, and represents a firm fixed-price transaction with no set-aside designation. Performance will occur at the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Tivicay 50 mg tablets (30-count units) under a firm fixed-price contract valued at $10,353.99. The award, issued on August 14, 2025, with an ultimate completion date of August 15, 2025, represents a non-competitive delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for TIVICAY 50 mg tablets (30-count units) valued at $5,448.89 under a firm fixed-price contract type. The award, issued on August 4, 2025, with an ultimate completion date of August 5, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate office location. This delivery order is a child contract...
- The Defense Logistics Agency awarded a delivery order valued at approximately $41K to AmerisourceBergen Drug Corp for the supply of Tivicay 50 mg tablets (30-count units) under a firm fixed price contract type. This award, issued on August 8, 2025, with an ultimate completion date of August 11, 2025, represents a competitive procurement with no set-aside designation. The product will be delivered to the contractor's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Tivicay 50 mg tablets (30-count) valued at $2,871.67 on July 25, 2025, with completion expected by July 28, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $24,055.34 to AmerisourceBergen Drug Corp for the supply of TIVICAY 50 mg tablets (30-count packages) on August 5, 2025, with completion scheduled for August 6, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical...
- The U.S. Defense Logistics Agency (DLA) awarded a $13,159.40 delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply 4,565,295,968 units of the HIV medication Tivicay 50 mg tablets. The contract has a firm fixed price and an ultimate completion date of July 31, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical for providing a...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $4,002.93 by the Defense Logistics Agency on August 15, 2025, for the supply of Tivicay 50 mg tablets (30-count units). This competitively awarded, non-set-aside delivery order carries a firm fixed price structure with an ultimate completion date of August 18, 2025, and will be performed at the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency Troop Support Medical awarded a $4,850 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 50mg tablets of Tivicay. Under this contract, Amerisourcebergen will deliver 30 tablets of the HIV medication from its facility in Conshohocken, Pennsylvania to an unknown customer by September 1, 2023. No additional details were provided regarding the original solicitation or whether this delivery order was placed against an existing indefinite...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMXTEDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,277.11 to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Tivicay 50 mg tablets (30-count units). This is a firm fixed price delivery order with no set-aside designation, representing a competitive award under the company's existing contract vehicle. Performance will occur at the awardee's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 14, 2025. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract SPE2DX), which carries a total value of $999,999,999.00 and runs through December 2026. As a pharmaceutical prime vendor serving the Defense Health Agency and broader military healthcare systems, AmerisourceBergen utilizes this comprehensive contract vehicle to supply medications, vaccines, and medical supplies worldwide. Tivicay, an antiretroviral medication used in HIV treatment, falls within the company's portfolio of specialty pharmaceuticals delivered through DLA's medical supply chain to support military and veteran healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 8/13/25 |